C.R. Bard, Inc. 

(Public, NYSE:BCR)   Watch this stock   
Find more results for BCR
Dec 17, 2009
Analyst Meeting 2009 - 4:30PM EST - Add to calendar
Oct 21, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 21, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 20.41% 16.99%
Operating margin 29.07% 22.43%
EBITD margin - 26.24%
Return on average assets 18.72% 16.20%
Return on average equity 24.26% 21.78%
Employees 11,000 -

Address

730 Central Avenue
Murray Hill, NJ 07974
United States - Map
+1-908-2778000 (Phone)
+1-908-2778240 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

C.R. Bard, Inc. discussed on blogs

Ranking 700+ Mid-Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 12 hours ago

C.R. Bard, Inc. discussions

  View all discussions »

Description

C. R. Bard, Inc. (Bard) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells a range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard has four product group categories: vascular, urology, oncology and surgical specialties. On January 11, 2008, Bard acquired LifeStent family of stents from Edwards Lifesciences Corporation. On June 5, 2008, the Company acquired Specialized Health Products International, Inc.

Officers and directors

Timothy M. Ring
Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation - Reuters
John H. Weiland
President, Chief Operating Officer, Director
Age: 53
Bio & Compensation - Reuters
Todd C. Schermerhorn
Chief Financial Officer, Senior Vice President
Age: 48
Bio & Compensation - Reuters
John A. DeFord Ph.D.
Senior Vice President - Science, Technology and Clinical Affairs
Age: 47
Bio & Compensation - Reuters
Gary D. Dolch
Senior Vice President - Quality and Regulatory Affairs
Age: 61
Bio & Compensation - Reuters
Stephen J. Long
Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation - Reuters
Frank Lupisella Jr.
Vice President, Controller
Age: 48
Bio & Compensation - Reuters
Bronwen K. Kelly
Vice President - Human Resources
Age: 56
Bio & Compensation - Reuters
Brian P. Kelly
Group Vice President - Corporate Healthcare Services
Age: 50
Bio & Compensation - Reuters
Sharon M. Alterio
Group Vice President
Age: 46
Bio & Compensation - Reuters